NACFC | Plenary 1: Hope for All: Addressing the Needs of Those With Untreated CF Mutations
CF Foundation | NACFC Highlights and Q+A
CF Foundation | Plenary 1: Emerging Technologies for CFTR Restoration in All People With CF
NACFC 2023 | W25: Best Abstracts in Endocrinology
CF Foundation | Kaylee Alvarado's Cystic Fibrosis Story
NACFC 2022 | W27: Impact of Trikafta: Unanticipated Psychosocial Challenges
NACFC 2023 | W16: Pathogenesis of Infection
NACFC 2023 | W18: Novel Psychosocial Interventions
Stephanie presents research findings from North American Cystic Fibrosis Conference (NACFC)
NACFC 2023 | Genetic Therapies for All: Harnessing Cross-Disease Knowledge for Breakthroughs in CF
NACFC 2020 | Plenary 3: Advancing the GI Frontier for People With CF
NACFC 2023 | DG05 : Who You Gonna Call? Ethical Decision-Making in CF
NACFC 2023 | S26: The Evolution of CF Nutrition: A Review of Emerging Evidence
NACFC 2023 | LL08: Treatment of Multi-Drug Resistant Pulmonary Infections
NACFC 2023 | There is No Health Without Mental Health: Progress, Challenges, & Hope for the Future
CF Foundation | NACFC 2022 Highlights
NACFC 2022 | S19: Approaches to Nutrition in Cystic Fibrosis: Emerging Trends
NACFC 2023 | W02: Model Systems to Study Non-Pulmonary Manifestations of CF
NACFC | Plenary 3: Evolving With the Times: Staying Agile With a Diverse & Aging CF Population
NACFC 2020 | Discipline Group 6: Challenging Pharmacotherapy Issues Across the CF Continuum of Care
NACFC 2023 | “Micro-Management”: The Changing Face of Infections in CF
NACFC 2022 | L&L04: Making Sense out of CFTR Genotyping Reports: Legacies, Stars, and Symbols
CF Foundation | Abigail McLain's Cystic Fibrosis Story
NACFC 2021 | Plenary 2: Working Together to Pave the Path to a Cure
NACFC 2020 | S10: CFTR Modulators: What We Are Learning
NACFC 2023 | W08: Lung Transplant Updates, What's New?!
NACFC 2022 | W07: Real World Evidence and Epidemiology in Cystic Fibrosis
NACFC 2023 | S15: Evolving Models of CF Care
CF Foundation | Plenary 2: Entering the Era of Highly Effective Modulator Therapy
NACFC 2023 | DG16: Research Coordinator Updates and Special Case Presentations
NACFC 2023 | DG15: Pulmonary Function Tests (PFT) Interpretation 101: What is in the Numbers?
NACFC 2023 | DG17: Bringing Health Equity Into the CF Clinic
NACFC 2023 | DG20: Hot Topics in Nursing
Short Notes On Cystic Fibrosis
NACFC 2023 | DG14: Seeing More Than CF: Care Team and Caregiver Perspectives
NACFC | Plenary 2: Novel CF Therapeutics & Clinical Trial Strategy to Accelerate Our Mission
NACFC 2023 | W11: Psychosocial Research Showcase
NACFC 2023 | S16: Decoding Complex CF Care
NACFC 2023 | S17: CFTR Structure, Function, and Cellular Biology
NACFC 2022 | S08: Aging with CF
NACFC 2022 | S01: Design of Clinical Trials to Evaluate Nucleotide-Based Interventions
NACFC 2022 | S09: Being on the Spectrum: CFTR-Related Disorders Revisited
NACFC 2023 | S22: Let’s Focus on ADHD and Executive Functioning
CF Foundation | Melanie Lawrence Lobbies the U.S. Senate
NACFC 2023 | LL12: Excellent Teams
NACFC 2021 | Plenary 1: Meeting the Moment: Lessons for a Changing World
NACFC 2020: GI Manifestations in Cystic Fibrosis
Cystic Fibrosis Foundation: Interviews in the Exhibit Hall with 2013 NACFC Attendees
CF Foundation | NACFC Reflections from Dr. William Skach
NACFC 2021 | S19: Hot Topics in Cystic Fibrosis Pulmonary Disease
NACFC 2023 | W32: What does CFTR do Outside the Lung?
NACFC 2023 | S06: Trauma-Informed Care for the Healthcare Team
NACFC 2023 | W04: Best Practice and Innovative Approaches to Clinical Research
NACFC 2022 | S26: Guidelines to Implementation
NACFC 2023 | W29: Accelerating Progress Along the Path to a Cure
NACFC 2023 | S27: CF Newborn Screening: From Implementation to Optimization & Equity
NACFC 2023 | S19: Let’s Be Blunt: Cannabis Use in CF
NACFC 2023 | W03: Pulmonary Vascular Biology & Lung Transplantation
CF Foundation | Therapeutics Pipeline 2001-2022
NACFC 2020 | S04: Cystic Fibrosis-Related Diabetes Unresolved Clinical Questions